Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.

The debt refinancing is expected to help the company in the impending spinoff of its eye-care company, Bausch + Lomb. This drugmaker is expected to post quarterly earnings of $1.05 per share in ...

Eyecare company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial Times reported The stock of eyecare company Bausch + Lomb Corp. was up 14%on ...

Investing.com -- Bausch + Lomb (NYSE:BLCO) is exploring a potential sale as part of an effort to resolve issues related to its separation from parent company Bausch Health, which is burdened with ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bausch + Lomb, one of the world’s largest contact lens suppliers, is exploring a sale as a way to clean ...

Harris said she would continue to work on a two-state solution “around the clock.” “In that solution there must be security for the Israeli people and Israel and in equal measure for the ...

As part of the deal, Bausch + Lomb will help scale commercialization of Trukera’s ScoutPro Osmolarity System, a device that measures tear osmolarity, or the salt content of a person’s tears, to help ...

3,4 As the health sector builds on these landmark achievements, it has the opportunity to embrace nature-based solutions—actions that protect, conserve, restore, sustainably use, and manage natural or ...

If you find 1 teaspoon of salt to be too strong, cut back to 1/2 teaspoon. Make a fresh solution for each use. Unless otherwise directed by your dentist or healthcare provider, swish the solution ...

Dr. Zihao Ou, assistant professor of physics at The University of Texas at Dallas, holds a vial of the common yellow food coloring tartrazine in solution. In an article published in Science ...